Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of JAK2 in Alveolar Macrophages in Chronic Beryllium Disease

NCT02596347 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT02596347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02596347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of JAK2 in Alveolar Macrophages in Chronic Beryllium Disease
Lead sponsor
National Jewish Health
Phase
Observational
Overall status
Completed
Start date
April 30, 2015
Completion date
December 6, 2019
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

beryllium sensitization (bes), chronic beryllium disease (cbd)